Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02579629 · ClinicalTrials.gov registry record · Phase 4
Use of On-Q Pump for Pain Post C-Section
A Phase 4 study, sponsored by Emory University.
- Completed
- Registry status
- Phase 4
- Development phase
- 64
- Enrollment target
NCT02579629 is a Phase 4 study that has completed, run by Emory University. The registered enrollment target is 64 participants.
The verdict
NCT02579629, a Phase 4 study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 64 participants
- Enrollment target
Study Summary
The main purpose of this study is to examine if pain levels treated with intrathecal (IT) preservative-free morphine (PFM) after a cesarean section improve with the additional use of continuous subfascial wound infiltration with ropivacaine using the OnQ® elastomeric pump system.
Interventions
- DRUG Normal saline
- DRUG Ropivacaine 0.1%
- DRUG Ropivacaine 0.2%
- DEVICE On-Q ® elastomeric pump
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2015-07 |
| Est. Completion | 2019-07-25 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02579629
The ClinicalTrials.gov registry entry for NCT02579629 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 64 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Normal saline is the first listed.
NCT02579629 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02579629 about?
NCT02579629 is a clinical study titled "Use of On-Q Pump for Pain Post C-Section". The main purpose of this study is to examine if pain levels treated with intrathecal (IT) preservative-free morphine (PFM) after a cesarean section improve with the additional use of continuous subfascial wound infiltration with ropivacaine using the OnQ® elastomeric pump system.
What is the current status of trial NCT02579629?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 64 participants. The study started on 2015-07. Estimated completion is 2019-07-25.
What interventions are being tested in trial NCT02579629?
The interventions under investigation include: Normal saline (DRUG), Ropivacaine 0.1% (DRUG), Ropivacaine 0.2% (DRUG), On-Q ® elastomeric pump (DEVICE).
Who is sponsoring clinical trial NCT02579629?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.